Traditional Chinese Medicine or Low-dose Dexamethasone in COVID-19 Pneumonia
Status:
Recruiting
Trial end date:
2024-12-31
Target enrollment:
Participant gender:
Summary
The goal of this type of clinical trial is to learn about symptomatic patients with
post-COVID-19 parenchymal lung abnormalities. The main questions it aims to answer are: the
efficacy and safety of low-dose dexamethasone or traditional Chinese medicine in symptomatic
patients with post-COVID-19 parenchymal lung abnormalities.
Participants will be divided into three parallel groups：controlled group with conventional
western medicine treatment including oxygen therapy, antibiotics, nebulization therapy, etc.
dexamethasone group: dexamethasone 1.5mg/day for one week and 0.75mg/day for another week
basing on conventional western medicine. Chinese medicine group: Strengthening spleen and
tonifying lung decoction for 2 weeks basing on conventional western medicine.